Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T72671 |
SARS-CoV-2-IN-12
|
||
SARS-CoV-2-IN-12 是一种有效的 SARS-CoV-2相关 3C 样蛋白酶抑制剂 (Ki=32.1 pM),可用于预防 SARS-CoV-2 病毒复制,用于 COVID-19 的研究。 | |||
T81210 |
SARS-CoV-2 Mpro-IN-12
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 Mpro-IN-12 (compound D026) 是一种抗SARS-CoV-2主要蛋白酶 (Mpro) 的抑制剂, 表现出抗病毒活性。 | |||
T60556 |
SARS-CoV-2-IN-16
|
||
SARS-CoV-2-IN-16 (Compound 12) 是SARS-CoV-2核衣壳蛋白的有效抑制剂,具有强效的抗病毒活性(EC50 = 3.69 μM)。SARS-CoV-2-IN-16 以7.82 μM 的低Kd 值与 NPro 结合,这表明 SARS-CoV-2-IN-16 是一种有效的 NPro 配体。 | |||
T68485 |
Apilimod HCl
|
||
Apilimod dimesylate is a potent and selective PIKfyve inhibitor. It exhibits no significant activity at other lipid kinases and protein kinases, including PIP4K, PIP5K, mTOR, PI3K and PI4K. Apilimod dimesylate inhibits cellular entry by SARS-CoV-2, MERS-CoV and MHV S pseudovirions. It reduces the number of SARS-CoV-2-infected hiPSC-derived pneumocyte-like cells by 85% and inhibits SARS-CoV-2 replication in donor lung tissue. It also exhibits selective cytotoxicity in B-cell non-Hodgkin lymphoma ... |